FDA chief: Cancer treatment comes with ‘financial toxicity’

Published April 12, 2018 2:22pm ET



The head of the Food and Drug Administration said far too many patients find themselves in “a financial no-man’s land” because of shouldering the costs of cancer medications.

The comments are the latest attack from FDA Commissioner Scott Gottlieb on drug prices and insurers.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.